STAT November 7, 2024
Adam Feuerstein, Allison DeAngelis, Elaine Chen

Is less regulation by the Food and Drug Administration good for the biotech industry? Do vaccine makers like Pfizer have a target on their back now? And will the “Make America Healthy Again” movement helmed by Robert F. Kennedy Jr. dampen the obesity drug market?

We discuss all that...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Congress / White House, FDA, Govt Agencies, Pharma / Biotech
Related Articles:
Congressional spending plan: What’s in it for healthcare, and what isn’t
Despite Trump’s Tough Talk On PBMs, GOP House Lets Them Off The Hook
Telehealth groups call for urgent action as Medicare flexibility deadline looms
Another House bill aims to protect against hospital cyberattacks
A health care earthquake in Congress

Share This Article